🔒

Welcome to SwitchTools

Save your favorite AI tools, build your personal stack, and get recommendations.

Continue with Google Continue with GitHub
or
Login with Email Maybe later →
📖

Top 100 AI Tools for Business

Save 100+ hours researching. Get instant access to the best AI tools across 20+ categories.

✨ Curated by SwitchTools Team
✓ 100 Hand-Picked ✓ 100% Free ✨ Instant Delivery

Qureight

0 user reviews Verified

Qureight is an AI clinical trial analytics platform that accelerates drug development for lung and heart diseases through imaging analysis and biomarker data curation.

Pricing Model
unknown
Skill Level
All Levels
Best For
PharmaceuticalsClinical ResearchHealthcareBiotech
Use Cases
Clinical Trial OptimizationCT Scan AnalysisDrug Development AccelerationBiomarker Discovery
Visit Site
4.5/5
Overall Score
4+
Features
1
Pricing Plans
0
User Reviews
Updated 25 May 2026
Was this helpful?

What is Qureight?

Qureight is an AI-powered clinical analytics platform built for biopharmaceutical companies, contract research organizations, and hospital networks conducting trials in respiratory and cardiovascular medicine. The platform combines proprietary CT imaging algorithms with structured data curation tools to compress the analysis phase of clinical trials — helping research teams reach go/no-go decisions faster without sacrificing data integrity. Drug development timelines are shaped significantly by the speed at which clinical imaging and biomarker data can be analyzed at scale. Qureight addresses this constraint by applying specialized deep learning algorithms to CT scan datasets — the same imaging modality that defines disease staging and treatment response in lung conditions such as IPF, COPD, and pulmonary hypertension. Teams can annotate, share, and collaboratively review imaging data across sites through a zero-footprint viewer, removing the need for local software installation at each research site. The platform's modular architecture supports multiple data types within a single structured environment: clinical imaging, lab biomarkers, electronic health record extracts, and sensor-derived measurements can all be organized and queried together. This unified structure reduces the manual data reconciliation work that typically delays interim analysis milestones. Regulatory bodies have explored Qureight for compliance monitoring use cases, and medical education institutions have piloted it for training radiologists on AI-assisted diagnostic workflows. Qureight's current algorithmic depth is concentrated in thoracic and cardiac imaging. Research programs focused on oncology imaging, neurology, or rare diseases outside the respiratory-cardiovascular space may find the specialized algorithms less applicable and should evaluate coverage before integration.

Qureight is an AI clinical trial analytics platform that accelerates drug development for lung and heart diseases through imaging analysis and biomarker data curation.

Qureight is widely used by professionals, developers, marketers, and creators to enhance their daily work and improve efficiency.

Key Features

1
AI-Driven Analytics
Applies deep learning models trained on clinical trial imaging and biomarker datasets to surface trial-relevant insights, helping research teams identify responders, track disease progression, and validate imaging endpoints with quantitative precision.
2
Proprietary Imaging Algorithms
Includes specialized CT analysis algorithms developed for lung and heart disease quantification — measuring features such as airway morphology, lung density distribution, and cardiac chamber dimensions that define response endpoints in respiratory and cardiovascular trials.
3
Collaborative Tools
Supports multi-site, multi-stakeholder data review through a zero-footprint browser-based viewer with annotation and markup capabilities, enabling principal investigators, sponsor teams, and CRO analysts to interact with the same imaging datasets without local software dependencies.
4
Comprehensive Data Structuring
Organizes imaging, biomarker, EHR, and sensor data into a unified structured format, reducing the manual reconciliation overhead that typically delays interim analysis submissions and trial milestone reporting.

Pros & Cons

✓ Pros (4)
Accelerated Drug Development Compresses imaging analysis and biomarker data structuring timelines, enabling sponsors to reach interim analysis readouts and regulatory submission milestones faster than manual data processing pipelines permit in multi-site trials.
Enhanced Accuracy Proprietary CT algorithms apply quantitative measurement to imaging endpoints that would otherwise rely on semi-quantitative radiologist scoring, reducing inter-reader variability and strengthening the statistical power of imaging-based trial outcomes.
Cost-Effective Reduces per-trial costs by shortening the data preparation and analysis phases that consume CRO resources, with faster trial completion timelines translating directly into reduced site monitoring and data management expenditure.
User-Friendly Interface The zero-footprint viewer with integrated AI model outputs requires no local installation, allowing multi-site research teams to review and annotate imaging data from any browser — reducing IT overhead for both sponsor and site teams.
✕ Cons (3)
Specialized Focus Qureight's proprietary imaging algorithms are currently optimized for thoracic and cardiovascular CT analysis. Trials centered on oncology imaging, neurological MRI, or ophthalmology endpoints will not benefit from the specialized algorithm library and may find generalist platforms more appropriate.
Learning Curve Research teams without prior experience in AI-assisted imaging analysis typically require structured onboarding to interpret algorithm outputs correctly and configure imaging endpoint definitions that align with regulatory submission standards.
Integration Complexity Connecting Qureight to existing CTMS platforms or electronic data capture systems used by clinical sites may require custom API configuration, adding technical scope to trial startup timelines at organizations with complex data architecture.

Who Uses Qureight?

Biopharmaceutical Companies
Using Qureight's imaging endpoints and biomarker data structuring to accelerate trial phase transitions, reducing the time between dosing milestones and interim analysis readouts in programs targeting IPF, COPD, and pulmonary arterial hypertension.
Hospitals
Deploying the platform's zero-footprint viewer and AI imaging analysis for improved diagnosis planning in lung and heart disease cases, integrating quantitative imaging insights alongside conventional radiologist reads.
Research Institutions
Leveraging Qureight to build structured imaging and biomarker datasets for academic publication and grant-funded research programs, where data organization and reproducibility are as important as analytical depth.
Healthcare Data Analysts
Running cross-trial data analyses by combining structured Qureight datasets with external registry data, producing insights on disease progression patterns that inform trial design for subsequent programs.
Uncommon Use Cases
National regulatory bodies have piloted Qureight for post-market surveillance of approved respiratory therapies using real-world imaging data; medical schools use the annotated CT datasets as training material for residents learning AI-assisted diagnostic interpretation.

Qureight vs MyMap AI vs GPT for Sheets and Docs vs Pabbly Connect

Detailed side-by-side comparison of Qureight with MyMap AI, GPT for Sheets and Docs, Pabbly Connect — pricing, features, pros & cons, and expert verdict.

Compare
Q
Qureight
unknown
Visit ↗
MyMap AI
Freemium
Visit ↗
GPT for Sheets and Docs
Freemium
Visit ↗
Pabbly Connect
Freemium
Visit ↗
💰Pricing
unknownFreemiumFreemiumFreemium
Rating
🆓Free Trial
Key Features
  • AI-Driven Analytics
  • Proprietary Imaging Algorithms
  • Collaborative Tools
  • Comprehensive Data Structuring
  • AI-Native
  • Multiple Format Upload
  • Web Search
  • Internet Access
  • Bulk Processing Capabilities
  • Diverse Model Selection
  • Versatile Use Cases
  • Ease of Integration
  • 2,000+ Integrations
  • No-Code Automation
  • Advanced Multi-Step Workflows
  • Cost-Effective Pricing
👍Pros
Compresses imaging analysis and biomarker data structur
Proprietary CT algorithms apply quantitative measuremen
Reduces per-trial costs by shortening the data preparat
Converting a 30-page document or a complex topic descri
The chat-based creation model means there is no interfa
MyMap accepts source material from text, documents, URL
Running a language model prompt across an entire Google
The freemium model provides access to base AI processin
The add-on integrates as a standard Google Workspace si
Features a logical, step-by-step wizard that simplifies
The lifetime deal provides massive long-term ROI, espec
Backed by an active Facebook group of 21,000+ members a
👎Cons
Qureight's proprietary imaging algorithms are currently
Research teams without prior experience in AI-assisted
Connecting Qureight to existing CTMS platforms or elect
The chat-based creation model is intuitive for simple d
MyMap AI requires an active internet connection for all
MyMap's AI-driven layout produces diagrams that are str
While the formula syntax is straightforward, writing ef
GPT-4 Turbo and Claude 3 model calls generate token-bas
GPT for Sheets and Docs operates exclusively within Goo
While no-code, mastering the logic of deep routers and
While it covers 2,000+ apps, some niche enterprise trig
Workflow reliability is tied to the API stability of th
🎯Best For
Biopharmaceutical CompaniesStudents & ResearchersContent CreatorsSmall to Medium-Sized Businesses
🏆Verdict
Qureight is the most focused option for CROs and biopharma s…
MyMap AI is the most accessible entry point for AI-generated…
For e-commerce managers, data analysts, and content teams wh…
Pabbly Connect is the 'utility player' of the automation wor…
🔗Try It
Visit Qureight ↗Visit MyMap AI ↗Visit GPT for Sheets and Docs ↗Visit Pabbly Connect ↗
🏆
Our Pick
Qureight
Qureight is the most focused option for CROs and biopharma sponsors running CT-heavy respiratory or cardiovascular trial
Try Qureight Free ↗

Qureight vs MyMap AI vs GPT for Sheets and Docs vs Pabbly Connect — Which is Better in 2026?

Choosing between Qureight, MyMap AI, GPT for Sheets and Docs, Pabbly Connect can be difficult. We compared these tools side-by-side on pricing, features, ease of use, and real user feedback.

Qureight vs MyMap AI

Qureight — Qureight is an AI Tool that brings purpose-built imaging algorithms and structured data management into clinical trials for lung and heart diseases, measurably

MyMap AI — MyMap AI is an AI Tool that generates diagrams and mind maps from conversational input, uploaded files, URLs, and live web search results. Its chat-native desig

  • Qureight: Best for Biopharmaceutical Companies, Hospitals, Research Institutions, Healthcare Data Analysts, Uncommon Us
  • MyMap AI: Best for Students & Researchers, Professionals, Content Creators, Educators, Uncommon Use Cases

Qureight vs GPT for Sheets and Docs

Qureight — Qureight is an AI Tool that brings purpose-built imaging algorithms and structured data management into clinical trials for lung and heart diseases, measurably

GPT for Sheets and Docs — GPT for Sheets and Docs is an AI Tool that brings multiple AI language models into Google Sheets and Docs through a simple add-on installation, enabling bulk te

  • Qureight: Best for Biopharmaceutical Companies, Hospitals, Research Institutions, Healthcare Data Analysts, Uncommon Us
  • GPT for Sheets and Docs: Best for Content Creators, Data Analysts, E-commerce Managers, Marketers, Uncommon Use Cases

Qureight vs Pabbly Connect

Qureight — Qureight is an AI Tool that brings purpose-built imaging algorithms and structured data management into clinical trials for lung and heart diseases, measurably

Pabbly Connect — Pabbly Connect is a high-value automation engine that disrupts the market with its 'pay-once' lifetime model. By offering 2,000+ integrations and a generous pol

  • Qureight: Best for Biopharmaceutical Companies, Hospitals, Research Institutions, Healthcare Data Analysts, Uncommon Us
  • Pabbly Connect: Best for Small to Medium-Sized Businesses, E-commerce Platforms, Marketing Agencies, Freelancers, Uncommon Us

Final Verdict

Qureight is the most focused option for CROs and biopharma sponsors running CT-heavy respiratory or cardiovascular trials — particularly where imaging endpoint variability is a primary risk. The primary limitation is that algorithm coverage for oncology and neurological imaging remains narrower than general-purpose clinical AI platforms like Medidata Rave Imaging.

FAQs

4 questions
What diseases does Qureight's imaging AI currently cover?
Qureight's proprietary algorithms are primarily optimized for lung and heart diseases, including conditions such as IPF, COPD, and pulmonary hypertension. The platform's CT analysis capabilities are most mature in thoracic imaging. Coverage for oncology, neurology, and other therapeutic areas is more limited and should be confirmed with Qureight's team before trial integration.
How does Qureight compare to general clinical data management platforms?
General CTMS platforms like Medidata Rave provide broad trial management functionality but lack disease-specific imaging algorithms. Qureight's differentiation lies in its proprietary CT quantification models for respiratory and cardiovascular endpoints, making it more applicable for imaging-heavy trials than a general data management solution built for adverse event tracking and data entry.
Does Qureight require labeled imaging data to deploy its algorithms?
Qureight's AI models are pre-trained on clinical imaging datasets and can be applied to new trial data without requiring the sponsor to provide labeled training examples. This reduces the upfront data preparation burden for trial teams and allows imaging analysis to begin as soon as baseline CT scans are collected and ingested into the platform.
Is Qureight suitable for academic research without commercial trial budgets?
Qureight serves research institutions alongside commercial pharma clients and has been used in grant-funded academic programs. However, deployment typically involves direct engagement with the Qureight team for scoping and configuration, as pricing and implementation support are not available through a self-service model.

Expert Verdict

Expert Verdict
Qureight is the most focused option for CROs and biopharma sponsors running CT-heavy respiratory or cardiovascular trials — particularly where imaging endpoint variability is a primary risk. The primary limitation is that algorithm coverage for oncology and neurological imaging remains narrower than general-purpose clinical AI platforms like Medidata Rave Imaging.

Summary

Qureight is an AI Tool that brings purpose-built imaging algorithms and structured data management into clinical trials for lung and heart diseases, measurably reducing time-to-decision for pharma sponsors and CROs. Its combination of CT analysis depth and collaborative multi-site data review offers a concrete ROI advantage in time-sensitive trials. The specialization that makes it effective in respiratory and cardiovascular research also defines its current ceiling for other therapeutic areas.

It is suitable for beginners as well as professionals who want to streamline their workflow and save time using advanced AI capabilities.

User Reviews

0 reviews
4.5
out of 5 · 0 reviews
5 ★
70%
4 ★
18%
3 ★
7%
2 ★
3%
1 ★
2%
✍️ Write a Review
Your Rating:
Select a rating
No account needed · Reviews are moderated before publishing
0 Reviews for Qureight

Alternatives to Qureight

6 tools
Q
Rate Qureight
Share your experience
How would you rate it?